| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity of pemetrexed (alimta), a new antifolate, against non-small cell lung cancer
|
Postmus, Pieter E
|
|
2002
|
38 |
S2 |
p. 3-7
5 p.
|
artikel
|
| 2 |
Alimta (pemetrexed disodium): a multitargeted antifolate for the treatment of mesothelioma
|
Green, Mark R
|
|
2002
|
38 |
S2 |
p. 55-57
3 p.
|
artikel
|
| 3 |
Contents
|
|
|
2002
|
38 |
S2 |
p. iii-
1 p.
|
artikel
|
| 4 |
Does chemotherapy have a role as palliative therapy for unfit or elderly patients with non-small-cell lung cancer?
|
Gridelli, Cesare
|
|
2002
|
38 |
S2 |
p. 45-50
6 p.
|
artikel
|
| 5 |
Gemcitabine and targeted therapies in thoracic cancer: present and future perspectives
|
Postmus, Pieter E.
|
|
2002
|
38 |
S2 |
p. 1-
1 p.
|
artikel
|
| 6 |
Gemcitabine/carboplatin in advanced non-small cell lung cancer
|
Zatloukal, Petr
|
|
2002
|
38 |
S2 |
p. 33-36
4 p.
|
artikel
|
| 7 |
Gemcitabine (Gemzar®)-based induction chemotherapy in non-small-cell lung cancer
|
Scagliotti, Giorgio Vittorio
|
|
2002
|
38 |
S2 |
p. 13-19
7 p.
|
artikel
|
| 8 |
Gemzar platinum combinations: phase III trials in non-small cell lung cancer
|
Crinò, Lucio
|
|
2002
|
38 |
S2 |
p. 9-12
4 p.
|
artikel
|
| 9 |
Healthcare outcomes: gemcitabine cost-effectiveness in the treatment of non-small cell lung cancer
|
Szczepura, Ala
|
|
2002
|
38 |
S2 |
p. 21-28
8 p.
|
artikel
|
| 10 |
IFC: Editorial board
|
|
|
2002
|
38 |
S2 |
p. IFC-
1 p.
|
artikel
|
| 11 |
Non-platinum gemcitabine combinations in non-small cell lung cancer
|
Marx, Gavin
|
|
2002
|
38 |
S2 |
p. 51-54
4 p.
|
artikel
|
| 12 |
Past, present, and future of gemcitabine and carboplatin regimens in advanced non-small cell lung cancer
|
Edelman, Martin J
|
|
2002
|
38 |
S2 |
p. 37-43
7 p.
|
artikel
|
| 13 |
Targeted therapy in non-small cell lung cancer
|
Giaccone, Giuseppe
|
|
2002
|
38 |
S2 |
p. 29-32
4 p.
|
artikel
|
Tijdschrift beschrijving